BHT Appoints Dr. Pamela Peeke as CMO, Adds Dr. Kian Beyzavi and Marcie Hamilton to Board
Bone Health Technologies (BHT) has announced the appointment of Dr. Pamela Peeke as its new Chief Medical Officer and board member. The company has also welcomed Dr. Kian Beyzavi and Marcie Hamilton as new board directors, reflecting its dedication to advancing the treatment of osteoporosis and osteopenia.
Dr. Peeke, an authority in women’s health, menopause, and longevity, is a clinical scientist and Assistant Professor of Medicine at the University of Maryland. Her expertise will contribute to BHT’s vision of providing a safe, non-pharmacological, clinically-proven solution for individuals with low bone density.
New board director Marcie Hamilton offers her expertise in medical devices and consumer products. After earning her B.S. in Mechanical Engineering from Purdue University, Hamilton made significant contributions to VivaRay Inc., leading to its acquisition by Varian Medical Systems. She later co-founded Potrero Medical, which developed a predictive technology platform for early detection of critical illnesses.
Dr. Kian Beyzavi, who also joins BHT’s board of directors, has a PhD in Electrical Engineering/Applied Physics from Princeton University. Dr. Beyzavi focuses on leveraging dynamic data, AI, and machine learning to drive advances in patient care and provide a holistic view of the healthcare landscape. She has been instrumental in the development of numerous MedTech, Digital Health, and Biopharma products across 60 companies.
The addition of these experienced professionals will strengthen BHT’s product development, research, and commercial growth, solidifying its position as a leader in treating osteoporosis and osteopenia.